Bookmark and Share
Urethane (CID 5641) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(10)
 
 
Inactive(426)
 
 
Inconclusive(50)
 
 
Unspecified(281)
 
 
Top Targets:
NR LBD PPAR(24)
 
 
 
NR LBD ER(23)
 
 
 
 
NR LBD AR(22)
 
 
 
 
7TM GPCR Srsx(17)
 
 
 
7TM GPCR Srx(17)
 
 
BioAssay Types:
Confirmatory(385)
 
 
 
 
Summary(72)
 
 
 
Literature(68)
 
 
 
 
Screening(6)
 
 
BioActivity Types:
Potency(320)
 
 
 
IC50(116)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 528    Data Row: 767   Total Pages: 39   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID67630]
NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID328, Type: other]
View
2
[SID67630]
NCI In Vivo Anticancer Drug Screen. Data for tumor model Lieberman Plasma Cell No. 1 (LPC-1) (intraperitoneal) in unknown mice [AID344, Type: other]
View
3
[SID48414619]
DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results [AID1189, Type: other]
View
4
[SID48414619]
DSSTox (CPDBAS) Carcinogenic Potency Database Summary Dog & Primates Bioassay Results [AID1190, Type: other]
View
5
[SID48414619]
DSSTox (CPDBAS) Carcinogenic Potency Database Summary Hamster Bioassay Results [AID1191, Type: other]
View
6
[SID48414619]
DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity [AID1194, Type: other]
View
7
[SID48414619]
DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results [AID1199, Type: other]
View
8
[SID48414619]
DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results [AID1205, Type: other]
View
9
[SID48414619]
DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results [AID1208, Type: other]
View
10
[SID48414899]
DSSTox (EPAFHM) EPA Fathead Minnow Acute Toxicity [AID1188, Type: other]
View
11
[SID8149977]
Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU) [AID1593, Type: other]
View
12
[SID8149977]
Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel) [AID1603, Type: other]
View
13
[SID8149977]
Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG) [AID1604, Type: other]
View
14
[SID8149977]
Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1) [AID1605, Type: other]
View
15
[SID8149977]
Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3) [AID1583, Type: other]
View
16
[SID8149977]
Screen for compounds that induce the human heat shock transcriptional response (HSEluc) [AID1611, Type: other]
View
17
[SID8149977]
Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE) [AID1612, Type: other]
View
18
[SID8149977]
Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1) [AID1613, Type: other]
View
19
[SID8149977]
Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80) [AID1614, Type: other]
View
20
[SID8149977]
Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH) [AID1616, Type: other]
View